ACE Funding Goal

Karen Ruberry and Jan McKnight, 2005 ACE Co-Chairs present ACE proceeds of $375,000 to Doug Silverstein, President, Glenbrook Hospital.

Breast and Ovarian Cancer Research at Evanston Northwestern Healthcare

Research is hope, and at the ENH Research Institute breast and ovarian cancer research is a priority.

A focus on translational research—bringing laboratory findings to the bedside—means patients have more choices today. Findings from lab and clinical studies are adapted into immediate benefits in patient care.

Innovative and aggressive research programs for breast and ovarian cancer continue to grow as Evanston Northwestern Healthcare recruits prominent physician-scientists from other leading institutions like Harvard Medical School. Directors of the new divisions of Cancer Biology and Molecular Oncology are among the recent recruits joining the ranks of talented researchers here working to develop new ways to prevent, diagnose and treat cancer.

More than 100 researchers are engaged in breast and ovarian cancer studies at Evanston Northwestern Healthcare encompassing an array of multi-disciplinary programs involving medicine, surgery, genetics and quality of life issues.

Ground-breaking studies underway include work to identify genetic markers for early diagnosis of breast cancer, review the effects of dietary fatty acids on breast cancer, and develop a pharmacologic approach to preventing ovarian cancer.

While ENH Research Institute programs have attracted significant funding from the National Institutes of Health (NIH) and other important organizations, there remains a critical need for philanthropic support to advance new and related studies.

Success in the battle against breast and ovarian cancer depends on the efforts of fundraising endeavors like the American Craft Exposition.

“Generous pilot grant
funding from ACE
allowed me to initiate
a study of breast MRI
in high-risk women.
As a result of study
participation, two women
were diagnosed with tiny
breast cancers which
were not detected by
standard screening
methods. They both
have excellent prognoses
because early cancer
detection was
accomplished. I feel that
the ACE funding helps
Evanston Northwestern
Healthcare investigators
to be leaders in breast
and ovarian cancer
research.”

Wendy Rubinstein, MD,
PhD, FACMG, Medical
Director Center for Medical
Genetics, Assistant
Professor, Northwestern
University Feinberg
School of Medicine

Make a Donation